Fig. 3

Well and disc diffusion assays for antibacterial and antifungal properties of MAgNPs against medically relevant pathogens. Kanamycin (Kan, 100 μg/mL), Gentamycin (Gen, 50 μg/mL), Vancomycin (Vanc, 50 μg/mL), Fluconazole (FLZ 50 mM) Magnolia Silver Nanoparticles (MAgNP, 0.07 mg/mL), Magnolia leaf extract (MLE), and Saline were exposed to a lawn of bacteria and grown at 37 °C for 24 h. (A) E. coli BL21, (B) Klebsiella pneumoniae, (C) Pseudomonas aeruginosa, (D) Enterococcus faecalis, (E) MSSA, (F) MRSA and (G and H) C. albicans. (G) 0.00086 mg/mL of MAgNPs and (H) 0.00043 mg/mL of MAgNPs.